Singapore markets closed

Lifecore Biomedical, Inc. (LFCR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
6.39+0.04 (+0.63%)
At close: 04:00PM EDT

Lifecore Biomedical, Inc.

3515 Lyman Boulevard
Chaska, MN 55318
United States
952 368 4300
https://www.lifecore.com

Sector(s)Healthcare
IndustryDrug Manufacturers - Specialty & Generic
Full-time employees459

Key executives

NameTitlePayExercisedYear born
Mr. James G. HallCEO, President & Director523.6kN/A1963
Mr. John D. MorbergExecutive VP & CFO520.82kN/A1964
Dr. Albert D. Bolles Ph.D.President of Curation Foods, Inc.1.34MN/A1958
Mr. Steve W. LaningaVice President of OperationsN/AN/AN/A
Dr. Kipling Thacker Ph.D.VP & Chief ScientistN/AN/A1955
Mr. Aaron PerlitshDirector of Internal Audit & Chief Compliance OfficerN/AN/AN/A
Mr. Darren M. HieberSenior Vice President of Corporate Development & PartnershipsN/AN/AN/A
Ms. Kara MorleySenior Vice President of Human ResourcesN/AN/AN/A
Ms. Jackie Q. KleckerExecutive VP & GMN/AN/AN/A
Mr. Matt AugustsonSenior Vice President of Information TechnologyN/AN/AN/A
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States and internationally. The company engages in the manufacturing of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.

Corporate governance

Lifecore Biomedical, Inc.’s ISS governance QualityScore as of 1 May 2024 is 5. The pillar scores are Audit: 10; Board: 4; Shareholder rights: 1; Compensation: 6.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.